Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Placebo for NOL-Guided Remifentanil Analgesia
NCT03912740Completed
- Sponsor
- Erasmus Hospital
- Start
- Apr 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in pain (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Intraoperative remifentanil consumption at 6 hours. Started Apr 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03912740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03912740.